Alset Inc., 10% Owner, Director at IMPACT BIOMEDICAL INC. (IBO), sold 2,697,037 shares at $0.58 ($1.8M) on 2025-04-02, disclosed to the SEC on 2025-04-04.
Open-market sale of $1.8M IBO by 10% Owner, Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.58 | 300,000 | $174K | 9.9% |
| 2 | $0.58 | 382,427 | $222K | 12.6% |
| 3 | $0.58 | 382,427 | $222K | 12.6% |
| 4 | $0.67 | 2,349 | $2K | 0.1% |
| 5 | $0.67 | 200,000 | $134K | 7.6% |
| 6 | $0.58 | 351,631 |
| $204K |
| 11.6% |
| 7 | $0.58 | 351,631 | $204K | 11.6% |
| 8 | $0.78 | 273,286 | $213K | 12.1% |
| 9 | $0.78 | 273,286 | $213K | 12.1% |
| 10 | $0.96 | 180,000 | $173K | 9.8% |
| Total | $0.65 avg | 2,697,037 | $1.8M | 100% |
| Filing → |